Showing 20 of 86 recruiting trials for “juvenile-myasthenia-gravis”
A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
RecruitingNCT06064461 ↗
Vitaccess Real MG Registry
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
RecruitingNCT06685055 ↗
Markers of Favorable Response to FcRn Inhibitors(INFORM)
👨⚕️ Raffaele Iorio, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Jul 2024View details ↗
A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
🏥 Shanghai Jiaolian Drug Research and Development Co., Ltd📍 18 sites📅 Started Jul 2024View details ↗
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
👨⚕️ Medical Responsible, EMD Serono Research & Development Institute, Inc.📍 132 sites📅 Started Jun 2024View details ↗
A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis
RecruitingNCT06455709 ↗
Markers of Favorable Response to Complement Inhibitors Therapy
👨⚕️ Raffaele Iorio, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Jun 2024View details ↗
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
RecruitingNCT06441825 ↗
Patient Observation With Environmental and Wearable Sensors in Myasthenia Gravis
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
RecruitingNCT06241521 ↗
Myasthenia Gravis Registry in China
RecruitingNCT04535843 ↗
Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →